Abstract Leptin is secreted into the bloodstream by adipocytes and is required for the maintenance of energy homeostasis and body weight. Leptin deficiency or genetic defects in the components of the leptin signaling pathways cause obesity. Leptin controls energy balance and body weight mainly through leptin receptor b (LEPRb)-expressing neurons in the brain, particularly in the hypothalamus. These LEPRb-expressing neurons function as the first-order neurons that project to the second-order neurons located within and outside the hypothalamus, forming a neural network that controls the energy homeostasis and body weight. Multiple factors, including inflammation and endoplasmic reticulum (ER) stress, contribute to leptin resistance. Leptin resistance is the key risk factor for obesity. This review is focused on recent advance about leptin action, leptin signaling, and leptin resistance.
Introduction
Obesity is closely associated with various metabolic disorders including dyslipidemia, cardiovascular disease, stroke, insulin resistance, and type 2 diabetes [1] . With the rapid upsurge of global obesity epidemic, obesity is becoming a challenging public health problem. In 2008, more than 1.4 billion adults worldwide were overweight (body mass index [BMI] ≥ 25), among which approximately 500 million adults worldwide were obese (BMI ≥ 30) [2] . Medical costs associated with obesity become a heavy social burden.
Body weight is determined by energy intake and energy expenditure [3] . Energy balance is maintained by adipose tissue-brain crosstalk, and energy imbalance results in an accumulation of excessive calories in the form of triglycerides in adipose tissue, leading to overweight and obesity. Adipose tissue secrets a variety of humoral factors, collectively called adipokines which regulate nutrient metabolism. Some adipokines (e.g., leptin) serve as adiposity signals to convey the information about the body energy storage and availability to the brain. The brain, particularly the hypothalamus, senses and integrates these adiposity signals and maintains energy homeostasis and body weight by controlling feeding behavior and energy expenditure.
Leptin is required for the maintenance of energy homeostasis and normal body weight [3] . Leptin is encoded by the ob gene that was identified by Friedman and colleagues in 1994 [4] . Afterwards, numerous studies established the crucial role of leptin in controlling energy balance and body weight in both rodents and humans. In mice, genetic leptin deficiency (ob/ob mice) or lack of functional leptin receptors (db/db mice) results in morbid obesity and type 2 diabetes [4, 5] . Albeit rare, congenital leptin deficiency causes severe hyperphagia and early-onset obesity in humans [6] [7] [8] . As expected, a leptin replacement therapy reverses obesity and significantly improves obesity-associated metabolic disorders in leptin-deficiency patients [8] [9] [10] [11] . Surprisingly, in most cases, circulating leptin levels are abnormally higher in patients with obesity. These patients are believed to develop leptin resistance, defined by the reduced ability of leptin to suppress appetite and weight gains. How does leptin resistance develop? What are the molecular mechanisms underlying leptin resistance? Can leptin resistance be corrected? In this review, we focus on leptin signaling pathways, highlighting the current understanding of leptin resistance.
white adipose tissue and secreted into the circulation [12] . Leptin expression is regulated by a variety of hormones, including insulin, glucocorticoids, and leptin itself [13] . FOSlike antigen 2 (FOSL2) is a key transcription factor that controls leptin expression in adipocytes [14] . Circulating leptin levels are in proportion to body fat mass, thus serving as a key adiposity signal [15, 16] . Circulating leptin levels also fluctuate in accord with changes in nutritional states, and fasting decreases plasma leptin levels [17] . Leptin is also expressed at low levels in other tissue, including bone marrow, ovary, placenta, stomach, and lymphoid tissue [13, 18] ; however, the physiological function of this locally produced leptin remains largely unknown.
The central nervous system (CNS), particularly the hypothalamus, is believed to be the main leptin target that mediates leptin's anti-obesity action [19, 20] . Leptin exerts its biological action through binding to and activating the long form of leptin receptors (LEPRb) that is expressed in many brain areas [21] [22] [23] [24] . Administration of leptin antagonists robustly increases food consumption and body weight in mice, indicating the importance of leptin binding to its cognate receptor(s) in controlling energy homeostasis [25, 26] . In addition to the brain, LEPRb is also expressed in peripheral tissue, but the physiological function of peripheral LEPRb remains to be determined [5, 27] . A single Lepr gene produces six LEPR isoforms (LEPRa, b, c, d, e, and f) via alternative mRNA splicing, and all isoforms have the identical N-terminal extracellular domain that binds to leptin [27, 28] . These isoforms differ in their C-terminal intracellular domains and are divided into three categories: short (LEPRa, c, d, and f), long (LEPRb), and secreted (LEPRe) forms [29] . LEPRb is the only form that has a fulllength intracellular domain of approximate 300 amino acid residues and mediates leptin signaling [30] [31] [32] . As expected, LEPRb-deficient db/db mice display the obesity phenotypes similar to that in leptin-deficient ob/ob mice and in db 3J (Fig. 1 ). LEPRb appears to be able to regulate nutrient metabolism by an additional mechanism independently of phosphorylation of Tyr 985 , Tyr
1077
, and Tyr 1138 . Mice with a replacement of all the three Tyr with Phe residues display the obesity phenotypes to a similar degree as db/db mice; however, db/db mice have more severe diabetic phenotypes [28, 44] .
IRS/PI3K signaling
The insulin receptor substrate (IRS)/phosphoinositide 3-kinase (PI3K) pathway is also required for leptin action [44, 60] . Leptin activates the IRS/PI3K pathway both in cultured cells and in the hypothalamus [28, [61] [62] [63] . Deletion of IRS2 in the brain causes obesity in mice [64, 65] . Pharmacological inhibition of PI3K in the hypothalamus prevents leptin-induced anorexia in mice [60] . Mechanistically, we showed that SH2B1, a SH2 domain-containing adaptor protein, binds to both JAK2 and the IRS proteins and mediates the activation of the PI3K pathway by leptin (Fig. 1) [66]. Disruption of the SH2B1 gene results in leptin resistance and obesity [67, 68] . Two downstream events of the PI3K cascades are described below [69] .
The forkhead box O1 (FoxO1) signaling branch One important downstream effector of the PI3K/Akt pathway is FoxO1, a key transcription factor for nutrient homeostasis [70] . Akt phosphorylates FoxO1 on multiple sites, resulting in cytoplasmic retention and inactivation of FoxO1 [69] . Overexpression of a constitutively active FoxO1 mutant in the arcuate nucleus (ARC) abolishes leptin responses and increases food intake and body weight, whereas overexpression of a transcription-deficient FoxO1 mutant or FoxO1 knockdown in the ARC has an opposite effect [70, 71] . Deletion of FoxO1 in POMC neurons results in decreased food intake and body weight in mice [72] . Deletion of IRS2 in LEPRb neurons leads to energy imbalance and obesity, and deletion of FoxO1 reverses the obesity phenotypes in IRS2 null mice [73] . Mechanistically, FoxO1 regulates the expression of important neuropeptides including POMC, NPY, and AgRP, and it also antagonizes STAT3 action [71, 74] .
The mammalian target of rapamycin complex 1 (mTORC1)/ ribosomal S6 kinase (S6K) signaling branch The mTOR/S6K pathway is another downstream event of the IRS/PI3K pathway [28] . Leptin stimulates the activation of the mTOR complex 1 (mTORC1), which in turn phosphorylates and activates S6K in the hypothalamus [75, 76] . Intracerebroventricular administration of L-leucine activates hypothalamic mTORC1 and decreases food intake and body weight in rats, whereas rapamycin, an mTORC1 inhibitor, exerts the opposite action [75] . Constitutive activation of S6K in the mediobasal hypothalamus (MBH) protects against HFD-induced obesity in rats, whereas inhibition of S6K activity in the MBH results in increased food intake and body weight [77] . These findings establish the critical role of the mTORC1/S6K pathway in mediating leptin regulation of energy homeostasis in mammals [75, 77] .
Other signaling pathways
The calcium/calmodulin-dependent protein kinase kinase (CaMKK2)/5′-AMP-activated protein kinase (AMPK)/ acetyl-CoA carboxylase (ACC) pathway has also been suggested to be involved in the leptin receptor signaling [28, 78, 79] . AMPK is activated by lower ATP/AMP ratios and serves as an intracellular sensor for energy levels [78] . Recently, we showed that glucose enhances leptin signaling through modulation of AMPK activity [80] . However, several key signaling steps of the CaMKK2/AMPK/ACC pathway in the leptin receptor signaling are yet to be defined. 104] , whereas activation of AgRP neurons is sufficient to stimulate food intake independently of the melanocortin system [105] . Leptin inhibits both AgRP neuronal activity and the expression of NPY and AgRP [28, 29, 90] . AgRP exerts its orexigenic action by acting both as an α-MSH antagonist and an MC4R inverse agonist [29, 106] . Genetic deletion of the NPY and/or AgRP genes has a mild effect on body weight in mice, suggesting the existence of other modulators in the AgRP neurons [107] . For example, synaptic release of gamma-aminobutyric acid (GABA) from AgRP neurons is suggested to provide an inhibitory mechanism for POMC neurons [108] . Surprisingly, deletion of LEPRs in either POMC or AgRP neurons results in a very mild obesity phenotype compared with that in db/db mice [89, 109] . Restoration of leptin signaling in the ARC of LEPR null animals modestly alleviates the hyperphagia and obesity phenotypes [110, 111] . These observations suggest that other LEPRb-expressing neurons also mediate leptin's action in addition to ARC POMC and AgRP neurons [112] . Indeed, LEPRs are expressed in many other brain areas beyond the ARC, and these extra-ARC sites account for 80%-85% of the total number of LEPR-expressing neurons in the brain [29] . Several recent studies report that LEPRb in the nitric oxide synthase-1 (NOS1)-expressing neurons and GABAergic neurons plays an important role in mediating the anti-obesity effects of leptin [112, 113] .
Leptin-targeted neural circuitry

Leptin-targeted neural circuits
LEPRb-expressing neurons serve as the first-order neurons to sense adiposity signals carried by leptin and other hormones and/or nutrients. They project to the second-order neurons located in many hypothalamic areas (DMH, LHA, and PVH) as well as in extrahypothalamic sites (e.g., VTA, and the brain stem), forming a sophisticated neural network that regulates energy homeostasis and body weight (Fig. 2) [28,29]. For instance, the PVH receives intense neuronal projections from the ARC and DMH and serves as a common output to regulate energy expenditure and satiety [87] . ARC POMC neuron-derived α-MSH binds to and activates the MC4R in PVH neurons, stimulating the expression and secretion of thyrotropin-releasing hormone (TRH), which in turn promotes energy expenditure by activating the pituitary-thyroid axis [28, 114, 115] . In contrast, AgRP and NPY inhibit TRH secretion [114, 115] . Restoration of MC4R in the PVH rescues the hyperphagia and obesity phenotypes of MC4R null mice [116] . Interestingly, a subset of the PVH neurons also express functional LEPRb, suggesting that leptin is able to directly regulate the activity of a subset of the PVH neurons [117] . ARC neurons also innervate VMH/DMH neurons and regulate the expression of anorexigenic brain-derived neurotrophic factor (BDNF) in these neurons [118, 119] . Moreover, the hypothalamic neural connections are bidirectional, and VMH-derived BDNF may reciprocally modulate ARC neuronal activity [119] . Additionally, the hypothalamic melanocortin system also has cross-talk with the brainstemderived serotonin (BDS) system, which may also be involved in leptin regulation of bone mass and energy balance [120] .
Molecular mechanisms of leptin resistance
Leptin resistance is considered as the primary risk factor for the pathogenesis of overweight and obesity [121] . Many mechanisms have been proposed to explain leptin resistance, including impairment in leptin transportation, leptin signaling, and leptin-targeted neural circuits [121, 122] . In addition to its effects on the CNS, leptin may also regulate the activity of peripheral tissue including pancreatic β cells, skeletal muscle, adipose tissue, liver, kidney, and immune cells [13, 123, 124] . Peripheral leptin resistance may develop in parallel to central leptin resistance, contributing to metabolic disorders [122] . There are several nice reviews in literature discussing leptin action on the peripheral tissue [13, 122] .
Impairment in leptin transportation
The majority of LEPRb-expressing neurons in the brain are separated from circulating leptin by the blood-brain barrier (BBB). Leptin is actively transported across the BBB in a saturable manner [125] . Two short forms of LEPRa and LEPRe are believed to mediate leptin transport across the BBB [126] [127] [128] . Megalin (or LRP2, low-density lipoprotein receptor-related protein-2) deficiency results in decreased leptin levels in the cerebrospinal fluid (CSF), suggesting that megalin in the choroid plexus is also involved in leptin transport across the BBB [129] . Brain leptin transport is impaired in both humans and mice with obesity, thus contributing to leptin resistance [130] [131] [132] . In HFD-fed mice, leptin transport across the BBB is substantially decreased [132] . In obese subjects with severe hyperleptinemia, leptin levels in the CSF only marginally increase [131] . However, the contributions of impaired leptin transport to leptin resistance remain to be determined. Firstly, the neuronal projections of the ARC LEPRb-neurons are detected in the median eminence that lacks the BBB, and these neurons may directly expose to circulating leptin [122, 133] . Secondly, HFD feeding attenuates the anorexigenic effect of intracerebroventricular administration of leptin [130] . Thirdly, impairment in the brain leptin transport may be secondary to systemic leptin resistance during the pathogenesis of obesity [122, 134] .
Impairment in LEPRb signaling
Defects in each component of the LEPRb signaling cascades are expected to result in leptin resistance. We describe three potential mechanisms: reduction in the cell surface LEPRb levels, upregulation of negative regulators, and downregulation of positive regulators [28, 122] .
The majority of LEPRb are localized in the Golgi apparatus and endosomes, and the function of these intracellular LEPRb is unclear; a small portion of LEPRb is present at the plasma membrane [135, 136] . The LEPRb trafficking to the cell surface is mediated by multiple factors including BardetBiedl syndrome (BBS) proteins [137] . BBS deficiency impairs LEPRb trafficking and leptin signaling, resulting in obesity in both humans and mice [137, 138] . Additionally, the plasma membrane LEPRb is constitutively internalized via endocytosis in a ligand-independent manner [135] . A reduction in the plasma membrane LEPRb expression, caused by a decrease in trafficking and/or increase in endocytosis, is expected to contribute to leptin resistance.
Leptin signaling is negatively regulated by many intracellular proteins, including SOCS3, protein tyrosine phosphatase 1B (PTP1B), and T cell protein tyrosine phosphatase (TCPTP) (Fig. 1) [139] [140] [141] . SOCS3 is a leptin-targeted gene and provides a negative feedback regulatory mechanism to prevent over-activation of the LEPRb pathways [139] . In agreement with this idea, mice with LEPRb overexpression in the POMC neurons are more susceptible to HFD-induced obesity [142] . SOCS3 inhibits JAK2 kinase activity by directly binding to JAK2 [143] . As discussed previously, SOCS3 also binds to phospho-Tyr 985 and inhibits LEPRb signaling [57,59]. Systemic haploinsufficiency of SOCS3 improves leptin sensitivity and attenuates HFD-induced obesity in mice [144] . Neuron-specific deletion of SOCS3 also protects against diet-induced leptin resistance and obesity [145, 146] . In contrast, transgenic overexpression of SOCS3 in POMC neurons leads to leptin resistance and obesity [147] . The levels of hypothalamic SOCS3 are higher in HFD-fed or aged mice, which may contribute to leptin resistance [139] . PTP1B, a class 1 non-receptor protein tyrosine phosphatase, dephosphorylates and inhibits JAK2 [140, 148] . PTP1B null mice are protected from diet-induced leptin resistance and obesity [148, 149] . Neuronal deletion of the PTP1B gene results in decreased food intake and increased energy expenditure [150, 151] . Ablation of PTP1B in POMC neurons also leads to elevated energy expenditure [152] . TCPTP, another non-receptor PTP, dephosphorylates STAT1 and STAT3 [55] . Inhibition of neuronal PCPTP improves leptin sensitivity in obese mice, and deletion of both PTP1B and TCPTP in the brain has an additive effect [141] . Furthermore, the expression of PTP1B and TCPTP in the hypothalamus is higher in mice with diet-induced obesity, providing additional evidence that PTP1B and TCPTP contribute to leptin resistance and the progression to obesity [141, 153, 154] . Additionally, phosphatase and tensin homolog (PTEN) and tyrosine phosphatase epsilon (RPTPe) are also suggested to be involved in the development of leptin resistance [155] [156] [157] [158] .
We have recently identified SH2B1 as a novel endogenous positive regulator of leptin signaling [66] [67] [68] 121, 159] . SH2B1 is an SH2 and pleckstrin homology (PH) domaincontaining adaptor protein and was initially identified as a JAK2-binding protein [160] . Deletion of the SH2B1 gene results in leptin resistance, hyperphagia, and morbid obesity [67] , and neuron-specific restoration of SH2B1 reverses the obesity phenotypes of SH2B1-deficient mice [68] . In agreement, ectopic expression of a dominant negative SH2B1 mutant in the brain causes obesity in wild-type mice [121] , whereas transgenic overexpression of SH2B1β in the brain protects mice from HFD-induced obesity [68] . SH2B1 appears to enhance LEPRb signaling by several mechanisms. Leptin stimulates JAK2 phosphorylation on Tyr 813 that in turn binds to the SH2 domain of SH2B1; SH2B1-JAK2 interactions increase JAK2 kinase activity, thus enhancing the activation of the pathways downstream of JAK2 [67, 159] . Leptin also stimulates the binding of SH2B1 to IRS proteins, thus allowing SH2B1-associated JAK2 to phosphorylate IRS proteins [66] . SH2B1-IRS interactions also inhibit tyrosine dephosphorylation of IRS proteins, thus prolonging the activation of the IRS-PI3K pathway [161] . The metabolic function of SH2B1 is evolutionarily conserved in fruit flies, mice, and humans [98, [162] [163] [164] [165] [166] [167] . Genome-wide association studies (GWAS) show that single nucleotide polymorphisms (SNPs) of the SH2B1 loci are linked to obesity in different ethnic populations [98, [163] [164] [165] [166] [167] . Chromosomal deletions of an SH2B1-containing fragment are associated with severe early-onset obesity in humans [168] .
Impairment in leptin-targeted neural circuits
The melanocortin system governs the hypothalamic neural circuitry that controls energy homeostasis. Deficiency of MC4R results in morbid obesity in both mice and humans [169] [170] [171] [172] . Leptin stimulates the expression of BDNF in the VMH via an MC4R-dependent mechanism [118] . Inhibition of the BDNF/TrkB pathways results in leptin resistance, hyperphagia, and obesity in both mice and humans, whereas activation of the BDNF/TrkB signaling induces weight loss in rats [118, [173] [174] [175] .
Potential contributors to leptin resistance in obesity
Many factors have been reported to cause leptin resistance in obesity. Here we discuss four factors: hyperleptinemia, inflammation, endoplasmic reticulum (ER) stress, and defective autophagy.
Hyperleptinemia
Hyperleptinemia per se is a contributing factor to development of leptin resistance. Chronic exposure to high levels of circulating leptin (hyperleptinemia) causes leptin resistance, presumably by over-activating negative feedback regulators [176] . In agreement with this idea, expression of a constitutively active form of STAT3 in POMC neurons results in leptin resistance, hyperphagia, and obesity [177] . Lowering plasma leptin levels through clamping does not prevent diet-induced obesity but significantly improves leptin sensitivity [177] . Both inhibiting adipocyte leptin production and increasing kidney leptin clearance are able to restore leptin sensitivity in mice [178] .
Inflammation
Low-grade, chronic inflammation is closely associated with various metabolic disorders including obesity [179] . HFD feeding promotes inflammation not only in the peripheral tissue but also in the hypothalamus [180, 181] . Saturated fatty acids, which are elevated in obesity, are able to bind to and activate Toll-like receptor 4 (TLR4) [182] . Intracerebroventricular administration of TLR4 neutralizing antibody diminishes the ability of saturated fatty acids to induce hypothalamic inflammation and suppress food intake and weight gain in rats [183] . Deletion of neuronal TLR adaptor molecule MyD88 protects against HFD-induced leptin resistance and obesity [184] . Both systemic and neuronspecific deletion of c-Jun N-terminal kinase 1 (JNK1), a key regulator of inflammation, protects mice from HFD-induced obesity [185, 186] . Activation of the hypothalamic IKKβ/NF-κB pathway induces leptin resistance, whereas inhibition of hypothalamic IKKβ protects against obesity in mice [181] .
ER stress
The ER is a cellular organelle where most secreted and transmembrane proteins are synthesized, folded, and sorted [187] . The ER processing capacity is affected by both the state of the cell and environmental conditions [187] . Protein overloading results in accumulation of unfolded or misfolded proteins in the ER lumens, causing ER stress. ER stress activates the unfolded protein response (UPR) pathways, including the inositol-requiring protein-1 (IRE1), activating transcription factor-6 (ATF6), and protein kinase RNA (PKR)-like ER kinase (PERK) pathways [187] . The UPR relieves ER stress by decreasing protein synthesis and influx into the ER, increasing protein-folding capacity of the ER via upregulating the expression of ER chaperons, and clearing unfolded or misfolded proteins from the ER through proteasome-mediated degradation [187] . Cell death is triggered if the UPR fails to relieve ER stress [187] . ER stress is associated with a variety of metabolic diseases including obesity, insulin resistance, and diabetes [188] . Recently, several groups have reported the role of ER stress in the development of leptin resistance and obesity [181, 189, 190] . Hypothalamic ER stress is observed in HFD-fed mice [189] . Deletion of neuronal X-box binding protein 1 (XBP-1), an important regulator of ER homeostasis, results in hypothalamic ER stress and leptin resistance [189] . Central administration of pharmacological ER stress inducers impairs leptin signaling, whereas treatments with chemical ER chaperons relieve hypothalamic ER stress and decrease body weight in ob/ob mice [189] [190] [191] . Physical exercises improve hypothalamic leptin sensitivity at least in part through suppressing hypothalamic IKKβ and ER stress in rodents [192] .
Defective autophagy
Autophagy has been reported to be involved in the regulation of energy homeostasis [193] [194] [195] [196] . Leptin treatments induce autophagy both in cultured cells and in animals [193] . Inhibition of autophagy in the mediobasal hypothalamus by knocking down autophagy-related protein 7 (Atg7) leads to energy imbalance and obesity in mice [194] . POMC neuronspecific Atg7-knockout mice display leptin resistance [196] ; in contrast, AgRP neuron-specific Atg7-knockout mice exhibit reduced body weight and adiposity without altering food intake [195] . Clearly, more studies are warranted to clarify the cell type-specific actions of autophagy under normal and obesity conditions.
Conclusions and future directions
Leptin has been firmly established as the essential hormone for the maintenance of energy homeostasis and body weight, and leptin resistance has been widely recognized as the key risk factor for obesity. Leptin promotes weight loss primarily by activating the LEPRb pathways in the brain, particularly in the hypothalamus. These pathways act coordinately to mediate leptin's anti-obesity action. LEPRb-expressing neurons are located in many brain areas, and these neurons form a sophisticated network to control energy balance and body weight. Multiple factors, including inflammation and ER stress, have been identified as causal factors for leptin resistance. Genetic studies, including mouse genetic analysis and GWAS, have provided important information about potential obesity genes. However, the anatomic connection and synaptic transmission of the brain neural circuitry that control energy homeostasis and body weight remain largely unknown. The interactions between the neural circuits that mediate homeostatic and hedonic regulation of food intake are unclear. It is also unclear how the different branches of the LEPRb pathways act specifically and/or coordinately to regulate different aspects of feeding behavior and energy expenditure. A large portion of molecular events that lead to leptin resistance remains to be identified. Additionally, we just begin to appreciate the contribution of hypothalamus plasticity and neurogenesis to the maintenance of energy homeostasis and body weight. We expect to have exciting new findings in these areas in the future.
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